Tectonic Therapeutic (TECX) Income from Non-Controlling Interests (2023 - 2026)

Tectonic Therapeutic's (TECX) quarterly Income from Non-Controlling Interests came in at $25.2 million in Q1 2026, up 58.39% year-on-year from $15.9 million in Q1 2025, and up 30.95% on a QoQ basis from $19.2 million in Q4 2025.

Tectonic Therapeutic (TECX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has 4 years of Income from Non-Controlling Interests data on file, last reported at $25.2 million in Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests rose 58.39% year-over-year to $25.2 million in Q1 2026; TTM through Mar 2026 was $83.5 million, a 42.52% increase from a year earlier, with the FY2025 full-year figure at $74.3 million, up 28.09% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at $25.2 million, up from $19.2 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for TECX reached as high as $25.2 million in Q1 2026 and fell as low as $7.9 million in Q4 2023.
  • Historically, Income from Non-Controlling Interests has averaged $15.5 million across 4 years, with a median of $15.6 million in 2024.
  • Across the five-year window, Income from Non-Controlling Interests jumped 76.38% in 2024 and rose 4.2% in 2025, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $7.9 million in 2023, then surged by 56.07% to $12.3 million in 2024, then soared by 56.51% to $19.2 million in 2025, then jumped by 30.95% to $25.2 million in 2026.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $25.2 million in Q1 2026, $19.2 million in Q4 2025, and $19.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Tectonic Therapeutic 595.23 Mn 595.23 Mn - 25.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.20 Mn
Dec 31, 2025 19.25 Mn
Sep 30, 2025 19.06 Mn
Jun 30, 2025 20.04 Mn
Mar 31, 2025 15.91 Mn
Dec 31, 2024 12.30 Mn
Sep 30, 2024 17.73 Mn
Jun 30, 2024 12.68 Mn
Mar 31, 2024 15.27 Mn
Dec 31, 2023 7.88 Mn
Sep 30, 2023 10.05 Mn
Jun 30, 2023 10.46 Mn